Core Insights - The launch of the "Medical Exclusive Cloud" by Shandong Mobile's Rizhao branch marks a significant transition from traditional IT infrastructure to a smart medical cloud platform for Rizhao Traditional Chinese Medicine Hospital [1][2] Group 1: Identifying Pain Points - Rizhao Traditional Chinese Medicine Hospital, established in 1999, faces challenges with its traditional IT architecture, which has led to issues such as "information islands" due to over 20 core systems being severely heterogeneous [2] - The aging data center equipment is nearing saturation, making it difficult to support new system deployments, while maintenance costs are rising annually, creating a heavy burden on the hospital [2] Group 2: Architectural Innovation - The "ECSO+EIS Exclusive Cloud" service, developed in collaboration with the Cloud Capability Center, integrates an "intelligent skeleton" into the medical system [4] - The platform features elastic computing capabilities to handle peak traffic efficiently, significantly reducing patient wait times during high-demand periods [4] - A seven-layer security system is established to protect medical data, including a national encryption algorithm for TCM prescription data and real-time data backup [4] Group 3: Value Realization - Post-implementation, the time to generate imaging reports has decreased from 15 minutes to 3 minutes, and outpatient wait times have been reduced by 42%, enhancing consultation efficiency [6] - Equipment failure rates have dropped from 3.2 times per month to 0.3, ensuring continuous operation and higher efficiency for medical staff [6] - Annual maintenance costs have decreased by 35%, with the system supporting an average of 3,200 patients during peak flu season in 2025, achieving a 100% success rate for online appointments [6] Group 4: Industry Impact - Utilizing 5G private networks and dual-route bare fiber transmission technology, the Rizhao branch ensures real-time medical data interaction and business continuity, providing patients with a "zero-latency" diagnosis experience [8] - The smart cloud platform is gradually integrating with regional grassroots medical institutions, facilitating collaborative services such as result recognition and remote consultations [8] - By the end of 2025, the system is expected to cover over 80% of hospitals in the city, transforming medical digitization from "point breakthroughs" to "full collaboration," thereby injecting stronger digital momentum into healthcare in Shandong [8]

Group 1 - The article reflects on the notable figures who passed away in 2025, highlighting their contributions across various fields such as music, education, and science [1][3][4][8][17][25][27][29][33] - The piece emphasizes the impact of these individuals on their respective domains, showcasing their legacies and the void left by their departures [1][3][4][8][17][25][27][29][33] Group 2 - The article mentions the achievements of singer and actor Fang Datong, who passed away at the age of 41 due to pneumothorax, and his influence in the music industry [3][4] - It details the life and contributions of Liu Hongru, former chairman of the China Securities Regulatory Commission, who played a significant role in China's financial reforms [8][9] - The article highlights the legacy of Li Zhaoji, founder of the Henderson Land Development Company, who was a prominent figure in Hong Kong's real estate sector [13][14] - It discusses the contributions of Lu Daopei, a pioneer in hematology and stem cell transplantation, who passed away at the age of 93 [17][19] - The piece also covers the life of Cai Lan, a renowned food critic and writer, who was influential in the culinary world [21][22] - It reflects on the historical contributions of Xu Zhuoyun, a prominent historian, who passed away at the age of 95 [25][24] - The article concludes with the legacy of physicist Yang Zhenning, a Nobel laureate, who made significant contributions to theoretical physics [27][28]

山西省卫健委提供的数据显示，截至目前，全省345家医院实现影像数据互通共享，所有二级及以上医 院全面推行检查检验结果互认，有效缩短民众挂号、住院、检查等候时长，降低患者就医成本。 一码通行轻简就医 "以前去不同医院看病，钱包里得塞好几张就诊卡，丢了补卡麻烦，忘带了更是寸步难行，现在有了电 子健康卡，一个二维码到全省医院都能用。"太原退休教师王建国常年需定期就医，电子健康卡的普 及，解决了他就医带卡、补卡的烦恼。 这一服务的背后，是全省医疗数据资源的系统性整合与云端共享，曾经分散在各医疗机构的"信息孤 岛"被彻底打通，居民健康数据连贯汇聚，为医疗服务从便捷化向智慧化升级筑牢数据根基。 王建国口中的电子健康卡，是该省统一推出的医疗领域"数字身份证"，民众通过"晋康管家"微信小程序 即可申领，无需额外跑腿，便捷高效。目前，该电子健康卡已覆盖山西省卫健委直属医院，无缝对接挂 号、缴费、取药、报告查询等57类高频就医场景。 山西探索以"数据跑腿"为民众就医减负 中新网太原12月30日电 题：山西探索以"数据跑腿"为民众就医减负 中新网记者 范丽芳 "不用带一堆就诊卡，手机亮个码就能挂号缴费；在县里拍的片子，省城医院也认 ...

活动现场，与会人员参观了上海瑞金医院无锡分院门诊大厅、体检中心、内镜中心、特需门诊及特需体检中心等核心区域，近距离感受医院先进的诊疗设 备、优质的医疗服务和专业的健康管理体系。上海瑞金医院无锡分院发布了企业家健康服务多项举措以及"健康管理专家委员会"名单，并与无锡市工商 联、无锡市企业联合会签署了《无锡市关爱企业家健康合作协议》。 12月29日下午，无锡企业健康守护行动暨企业家健康管理中心揭牌活动在无锡高新区(新吴区)上海瑞金医院无锡分院举行。上海瑞金医院无锡分院将为无 锡企业家提供名医会诊、全流程健康体检就医陪诊等十项更便捷的就医服务。 无锡芯朋微电子股份有限公司董事长、无锡市半导体协会会长张立新表示，这次活动是无锡市委、市政府促进企业家健康成长和企业健康发展、优化营商 环境的生动体现，也是上海瑞金医院无锡分院践行社会责任、服务地方发展的具体行动，他倍感温暖。江苏大明工业科技集团副董事长邹晓平说："我非 常感谢无锡给我们企业家提供了一个这么好的为健康保驾护航的平台，在今后的工作中，我们也将带领企业员工以更加饱满的精神、更加强健的体魄，心 无旁骛干事业谋发展，为助力新时代工商名城建设多作贡献。" 扬子晚报/紫 ...

Core Viewpoint - The introduction of Optical Coherence Tomography (OCT) technology at Tengzhou Central People's Hospital marks a significant advancement in the precision diagnosis and treatment of coronary heart disease, enhancing the capabilities of interventional cardiology teams [1][2][4] Group 1: Technology and Equipment - The newly integrated device combines both OCT and Intravascular Ultrasound (IVUS) functionalities, allowing for rapid switching between imaging modes based on the characteristics of the lesions [4] - OCT technology achieves a resolution of 10 micrometers, which is ten times that of IVUS, enabling detailed visualization of vascular structures, including plaque types and the presence of microthrombi [2][4] Group 2: Clinical Application and Impact - The surgical team successfully utilized OCT to perform a critical procedure on a 60-year-old male patient, leading to the successful opening of a long-occluded artery and the implantation of a stent [1][2] - The use of OCT during surgery provided real-time imaging that significantly improved the accuracy of surgical planning, allowing for precise identification of narrow segments and the nature of plaques [2][4] - The application of OCT in clinical practice represents a shift from experience-driven to data-driven interventional treatment, ensuring high-quality care for coronary heart disease patients locally [4]

Core Insights - The Jinan Third People's Hospital Allergy Reaction Clinic has successfully implemented a "four-in-one" prevention and treatment model, utilizing multiple internationally leading anti-allergy therapies to improve the quality of life for patients with allergic diseases, marking a new phase in precise and standardized treatment in the eastern region of Jinan [1][2] Group 1: Treatment Innovations - The clinic has introduced targeted therapies such as Dupilumab for treating severe atopic dermatitis, achieving significant symptom relief and improved sleep quality for patients [1][6] - The use of Omalizumab, an anti-IgE monoclonal antibody, has shown to reduce acute attack frequency by 70% in over 80% of moderate to severe allergic asthma patients, with an average improvement of 25% in lung function (FEV1) [5] - The clinic employs subcutaneous desensitization therapy targeting house dust mite allergens, which has been effective in treating pediatric patients without significant adverse reactions [4] Group 2: Comprehensive Management Approach - The "four-in-one" prevention and treatment model includes precise allergen detection, environmental management, immune modulation, and standardized desensitization, leading to over 85% of patients experiencing significant symptom relief within three months and a reduction in recurrence rates by over 60% [2][3] - The clinic is equipped with advanced allergen detection platforms and pulmonary function rooms, ensuring comprehensive tracking from initial consultation to long-term follow-up [7] - The goal is to provide tailored treatment plans for each allergic patient, aiming not only to control symptoms but also to halt disease progression [7]

12月27日，菏泽市医学会骨科脊柱分会第二届第二次学术年会在山东省立医院菏泽医院东院区成功举 行。本次会议由菏泽市医学会主办，山东省立医院菏泽医院（菏泽市立医院）承办，旨在促进区域内脊 柱外科领域的学术交流与技术进步，提升临床诊疗水平。 开幕式上，菏泽市医学会副会长庞洪波、菏泽市立医院党委委员、副院长武海军分别致辞，对会议的召 开表示祝贺。武海军在致辞中介绍了菏泽市立医院近年来在专科学科建设方面取得的显著成就，特别是 2025年长江东路院区的建成开业，将打造成为"大专科小综合"的综合性院区，为菏泽及周边地区患者提 供更加优质的医疗服务。他强调，脊柱外科在张善地主任的带领下，多项专业手术填补了菏泽市空白， 治疗的疾病病种及手术量逐年增加，复杂疑难疾病的诊疗工作已常规开展，微创手术技术应用广泛。 会议邀请了省内外多位知名专家学者进行专题讲座和病例分享。山东第一医科大学附属省立医院丰荣杰 教授、王乃国教授、王国栋教授，天津市天津医院晁爱军教授等分别就显微镜下手术的优势、UBE手术 并发症的病例汇总及分析、骨质疏松骨折规范化诊疗、青少年特发性脊柱侧凸的诊断与治疗策略等热点 问题进行了深入探讨。 本次学术年会内容丰富、 ...

Core Insights - The U.S. IPO market is expected to experience explosive growth in 2025, with a total of 531 companies filing for IPOs with the SEC, representing a year-on-year increase of 55.72% [1] - Chinese companies are a significant contributor, with 147 applications, accounting for 27.68% of the total, making them the largest source of IPOs from outside the U.S. [1] - Among the 147 Chinese applicants, 89 are operational entities, and 24 have successfully listed on U.S. exchanges, including notable companies like Cha Tea (CHA), Pomegranate Cloud Medical (POM), and Giant Dragon Online (JLHL) [1] - However, 24 Chinese companies faced rejection from the SEC due to incomplete information in their "blank prospectuses," highlighting the importance of compliance in information disclosure for successful U.S. listings [1] - This trend reflects the global demand for quality enterprises and the vitality of the Chinese economy, indicating that going public in the U.S. remains a crucial path for internationalization [1] - Compliance and thorough information disclosure will be key factors for success in future U.S. listings [1]

Group 1 - The core viewpoint of the news is that Ruizhi Pharmaceutical has shown a decline in stock performance and financing activities, indicating a low level of investor confidence and market activity [1][2]. - As of December 29, 2023, Ruizhi Pharmaceutical's stock price fell by 0.62%, with a trading volume of 54.76 million yuan. The net financing amount was -3.51 million yuan, indicating more repayments than new purchases [1]. - The total financing and margin trading balance for Ruizhi Pharmaceutical is 154 million yuan, which accounts for 3.22% of its market capitalization, indicating a low financing level compared to the past year [1]. Group 2 - As of December 20, 2023, the number of shareholders for Ruizhi Pharmaceutical decreased by 1.92% to 38,600, while the average number of circulating shares per person increased by 1.96% to 12,307 shares [2]. - For the period from January to September 2025, Ruizhi Pharmaceutical reported a revenue of 817 million yuan, representing a year-on-year growth of 13.68%. The net profit attributable to shareholders was 7.09 million yuan, showing a significant increase of 111.50% year-on-year [2]. - The company has cumulatively distributed 180 million yuan in dividends since its A-share listing, but there have been no dividend distributions in the past three years [3].

除照顾弱势群体，相关措施还将避免中等收入人士出现大病致贫的情况，受惠病人数由目前约30万人大 幅增加至约140万人，再加上大约60万名综合社会保障援助受助人、75岁或以上长者生活津贴受助人及 长者院舍照顾服务券计划级别0院舍券持有人，预计将有约200万人受惠。 医管局主席范鸿龄说，改革各项措施全面落实后，可逐步扭转目前公立医院服务失衡的情况，也可以加 强对病人，特别是贫、急、重、危病人的保障，公营医疗服务得以持续发展，应对香港人口老化对医疗 系统带来的挑战。 医管局行政总裁李夏茵说，医管局各项系统，包括病人登记、收费、临床医疗等均已做好测试。所有系 统2026年1月1日零时会正式调整到新的收费模式，医管局会密切监察各公立医院的运作情况，确保收费 改革顺利推行。 责编：卢思宇、李萌 新华社香港12月29日电（记者刘媛媛）香港医院管理局29日表示，将于2026年1月1日全面推行公营医疗 收费改革的各项措施。这些举措不仅将有利于公营医疗发展，也将加强对贫、急、重、危病人的保障， 预计惠及约200万人。 改革举措实施后，医管局将全面加强对有需要病人的保障，通过优化医疗费用减免机制、扩大撒玛利亚 基金安全网和设立每年1 ...